Morocco Pharmaceuticals and Healthcare Report Q1 2013
1/16/2013 | published by: Business Monitor International
... the evidence ofbribery and corruption, and the shortage of doctors in the sector. BMI believes the commitment toimprove governance and implement controls in the sector will be fulfilled in the medium-to-long term. Assuch, we maintain ...
|
more...
|
$1,175.00
|
The U.S. Market for Rx to OTC Switches, 6th Edition
1/11/2013 | published by: Kalorama Information
... Kalorama Information has analyzed the market for drugs with switched ingredients in detail. The market is fueled by several factors including an aging population; steady to increased incidences of conditions and diseases; new drug classes ...
|
more...
|
$3,995.00
|
Incontinence in Slovenia
1/8/2013 | published by: Euromonitor International
... embarrassing condition. As is the case in much of Europe, Slovenia is a rapidly ageing society. According to the 2011 report “Ageing in Slovenia”, produced by the Statistical Office of Slovenia, from 1989 to 2009 ...
|
more...
|
$900.00
|
OTC Medications – US – a snapshot (2012)
1/2/2013 | published by: Mintel - Snapshots
... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in US is given in USD with a minimum ...
|
more...
|
$600.00
|
OTC Medications – Russia – a snapshot (2012)
1/2/2013 | published by: Mintel - Snapshots
... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Russia is given in RUB with a minimum ...
|
more...
|
$600.00
|
OTC Medications – UK – a snapshot (2012)
12/28/2012 | published by: Mintel - Snapshots
... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in UK is given in GBP with a minimum ...
|
more...
|
$600.00
|
Belgium Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... local currency and US dollar terms, largely on account of cost containmentmeasures and patent expirations. Nevertheless, foreign companies are expected to continue using Belgianproduction sites for exports, the country also being a popular re-export source. ...
|
more...
|
$1,175.00
|
Botswana Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... and healthcare companies, it is unlikely that the gap inhealthcare provision will be filled by private healthcare firms. We continue to maintain that given therelatively small pharmaceutical and healthcare market in Botswana, we do not ...
|
more...
|
$1,175.00
|
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... Cuban pharmaceutical firms revealing plans to set upplants in the country. But private investment is the exception, rather than the rule, in the country, withCôte d'Ivoire depending upon historical ties with France, Morocco and Tunisia ...
|
more...
|
$1,175.00
|
OTC Medications – Netherlands – a snapshot (2012)
12/19/2012 | published by: Mintel - Snapshots
... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Netherlands is given in EUR with a minimum ...
|
more...
|
$600.00
|
OTC Medications – China – a snapshot (2012)
12/18/2012 | published by: Mintel - Snapshots
... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in China is given in CNY with a minimum ...
|
more...
|
$600.00
|
Pharmaceuticals in France: ISIC 2423
12/18/2012 | published by: Euromonitor International
... the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new ...
|
more...
|
$600.00
|
OTC Medications – Malaysia – a snapshot (2012)
12/3/2012 | published by: Mintel - Snapshots
... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Malaysia is given in MYR with a minimum ...
|
more...
|
$600.00
|
OTC Medications – Italy – a snapshot (2012)
12/3/2012 | published by: Mintel - Snapshots
... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Italy is given in EUR with a minimum ...
|
more...
|
$600.00
|
OTC Medications – Poland – a snapshot (2012)
12/3/2012 | published by: Mintel - Snapshots
... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Poland is given in PLN with a minimum ...
|
more...
|
$600.00
|
OTC Medications – Denmark – a snapshot (2012)
12/3/2012 | published by: Mintel - Snapshots
... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Denmark is given in DKK with a minimum ...
|
more...
|
$600.00
|
OTC Medications – Japan – a snapshot (2012)
12/3/2012 | published by: Mintel - Snapshots
... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Japan is given in JPY with a minimum ...
|
more...
|
$600.00
|
OTC Medications – Vietnam – a snapshot (2012)
12/3/2012 | published by: Mintel - Snapshots
... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Vietnam is given in VND with a minimum ...
|
more...
|
$600.00
|
Pharmaceuticals: Global Industry Guide
11/30/2012 | published by: MarketLine
... and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis. Scope of the Report Contains an executive summary and data on value, volume and segmentation Provides ...
|
more...
|
$1,495.00
|
Pharmaceuticals: Global Industry Almanac
11/30/2012 | published by: MarketLine
... and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis. Scope of the Report Contains an executive summary and data on value, volume and segmentation Provides ...
|
more...
|
$2,995.00
|
Pharmaceuticals - Global Group of Eight (G8) Industry Guide
11/30/2012 | published by: MarketLine
... Russia and Japan) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the ...
|
more...
|
$1,495.00
|
|
|
$995.00
|
Pharmaceuticals - Scandinavia Industry Guide
11/30/2012 | published by: MarketLine
... market value, segmentation, and five forces analysis, plus full five year market forecasts for each country. It examines future problems, innovations and potential growth areas within the market. Scope of the Report Contains an executive ...
|
more...
|
$795.00
|
Pharmaceuticals - North America (NAFTA) Industry Guide
11/30/2012 | published by: MarketLine
... The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market. Scope of the ...
|
more...
|
$795.00
|
|
|
$3,500.00
|